- Home
- /
- Treatment
- /
- Page 128
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Pergolide | Tourette syndrome | Sallee, Floyd R. M.D., Ph.D.;Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave.;Cincinnati, Ohio, 45229 | November 20, 1997 | |
Calcium gluconate | For use as a wash for hydrofluoric acid spills on human skin | Calgonate Corp.;3310 South Ocean Blvd, Unit 132;Highland Beach, Florida, 33487 | November 20, 1997 | |
Pegylated recombinant human megakaryocyte growth and development factor | For reducing the period of thrombocytopenia in patients undergoing hematopoietic stem cell transplantation | Amgen, Inc.;One Amgen Center Dr.;Thousand Oaks, California, 91320 | October 20, 1997 | |
Apomorphine | For use as rescue treatment for early morning motor dysfunction in late-stage Parkinson's disease | Scherer DDS;Frankland Road, Swindon SN5 8RU;Wiltshire | October 20, 1997 | |
Recombinant human interleukin-12 | Renal cancer | Genetics Institute, Inc.;87 Cambridge Park Drive;Cambridge, Massachusetts, 02140 | October 20, 1997 | |
Alemtuzumab | Chronic lymphocytic leukemia | Genzyme Corporation;4545 Horizon Hill Blvd.;San Antonio, Texas, 78229 | October 20, 1997 | |
Recombinant human thrombopoietin | For use in accelerating platelet recovery in patients undergoing hematopoietic stem cell transplantation | Genentech, Inc.;1 DNA Way;South San Francisco, California, 94080 | September 29, 1997 | |
Purified extract of Pseudomonas aeruginosa | Immune thrombocytopenia | Able Laboratories, Inc.;200 Highland Avenue, Suite 30;Needham, Massachusetts, 02494 | September 22, 1997 | |
Testosterone | For use as physiologic testosterone replacement in androgen deficient HIV+ patients with an associated weight loss | Watson Laboratories;Research Park, 417 Wakara Way;Salt Lake City, Utah, 84108 | September 22, 1997 | |
Cysteamine hydrochloride | Corneal cystine crystal accumulation in cystinosis patients | Leadiant Biosciences, Inc.;9841 Washingtonian Blvd, Suite 500;Gaithersburg, Maryland, 20878 | August 19, 1997 | |
Recombinant human acid alpha-glucosidase; alglucosidase alfa | Glycogen storage disease type II | Genzyme Corporation;500 Kendall Street;Cambridge, Massachusetts, 02142 | August 19, 1997 | |
Alpha-melanocyte stimulating hormone | Prevention and treatment of intrinsic acute renal failure due to ischemia | National Institute of Diabetes, and Digestive and Kidney Diseases;National Institutes of Health, 31 Center Drive MSC, Building 31, Room 9N-222;Bethesda, Maryland, 20892 | August 19, 1997 | |
Short chain fatty acid enema | Chronic radiation proctitis | Richard I. Breuer, M.D.;1000 Central Street, Suite 615;Evanston, Illinois, 60201 | August 19, 1997 | |
Poloxamer 188 | Vasospasm in subarachnoid hemorrhage patients following surgical repair of a ruptured cerebral aneurysm | CytRx Corporation;154 Technology Parkway;Norcross, Georgia, 30092 | August 5, 1997 | |
Icodextrin 7.5% with Electrolytes Peritoneal Dialysis Solution | Those patients having end stage renal disease and requiring peritoneal dialysis treatment | Baxter Healthcare Corporation;Renal Division, 1620 Waukegan Road;McGaw Park, Illinois, 60085 | July 18, 1997 | |
Pentasaccharide ethyl glycoside consisting of one alpha-D-sialylosyl residue as a sodium salt, two beta-D-galactopyranosyl residues, one 2-acetamido-beta-D-glucopyranosyl unit, and one alpha-L-fucopyranosyl unit | Neonates and infants undergoing cardiopulmonary bypass during surgical repair of congenital heart lesions | Cytel Corporation;3525 John Hopkins Court;San Diego, California, 92121 | July 18, 1997 | |
Allogeneic human retinal pigment epithelial cells on gelatin microcarriers | Hoehn and Yahr stage 3 and 4 Parkinson's disease | Bayer Healthcare Pharmaceuticals, Inc.;100 Bayer Boulevard;Whippany, New Jersey, 07981 | July 18, 1997 | |
Busulfan | Primary brain malignancies | SuperGen, Inc.;Two Annabel Lane, Suite 220;San Ramon, California, 94583 | July 7, 1997 | |
Pegvisomant | Acromegaly | Sensus Corporation;Suite 430,, 98 San Jacinto Boulevard;Austin, Texas, 78701 | June 24, 1997 | |
Porcine Sertoli cells aseptically prepared for intracerebral co-implantation with fetal neural tissue | Hoehn and Yahr stage four and five Parkinson's disease | Titan Pharmaceuticals, Inc.;Post Office Plaza, 50 Division Street, Suite 503;Somerville, New Jersey, 08876 | June 24, 1997 | |
Allogeneic peripheral blood mononuclear cells sensitized against patient alloantigens by mixed lymphocyte culture | Pancreatic Cancer | Applied Immunotherapeutics, LLC;14132 E. Firestone Boulevard;Santa Fe Springs, California, 90670 | June 13, 1997 | |
Fampridine | Chronic, incomplete spinal cord injury | Acorda Therapeutics, Inc.;15 Skyline Dr.;Hawthorne, New York, 10532 | June 2, 1997 | |
Suramin | Hormone-refractory prostate cancer | Warner-Lambert Company;Parke-Davis Pharmaceutical Research Division, 2800 Plymouth Road;Ann Arbor, Michigan, 48105 | May 6, 1997 | |
Retroviral vector, R-GC and GC gene 1750 | Gaucher disease | Genzyme Corporation;500 Kendall Street;Cambridge, Massachusetts, 01701 | May 6, 1997 | |
Oxandrolone | Patients with Duchenne's muscular dystrophy and Becker's muscular dystrophy | Savient Pharmaceuticals, Inc.;One Tower Center Boulevard, 12th floor;East Brunswick, New Jersey, 08816 | April 22, 1997 |